Heterodimerization and cross-desensitization between the μ-opioid receptor and the chemokine CCR5 receptorCHONGGUANG CHEN; JIN LI; BOT, George et al.European journal of pharmacology. 2004, Vol 483, Num 2-3, pp 175-186, issn 0014-2999, 12 p.Article

Sensitivity Changes over the Course of Infection Increases the Likelihood of Resistance Against Fusion but Not CCR5 Receptor BlockersCHATZIANDREOU, Nikolaos; BELEN ARAUZ, Ana; FREITAS, Ines et al.AIDS research and human retroviruses. 2012, Vol 28, Num 12, pp 1584-1593, issn 0889-2229, 10 p.Article

Influence of Variations in CCL3L1 and CCR5 on Tuberculosis in a Northwestern Colombian PopulationMAMTANI, Manju; MUMMIDI, Srinivas; NDUNG'U, Thumbi et al.The Journal of infectious diseases. 2011, Vol 203, Num 11, pp 1590-1594, issn 0022-1899, 5 p.Article

CCR5 Mutations Distinguish N-Terminal Modifications of RANTES (CCL5) with Agonist versus Antagonist ActivityCHOI, Won-Tak; NEDELLEC, Rebecca; COETZER, Mia et al.Journal of virology. 2012, Vol 86, Num 18, pp 10218-10220, issn 0022-538X, 3 p.Article

Evolution of CCR5 Use before and during Coreceptor SwitchingCOETZER, Mia; NEDELLEC, Rebecca; SALKOWITZ, Janelle et al.Journal of virology. 2008, Vol 82, Num 23, pp 11758-11766, issn 0022-538X, 9 p.Article

Pharmacokinetic Interaction of Ritonavir-Boosted Elvitegravir and MaravirocRAMANATHAN, Srinivasan; ABEL, Samantha; TWEEDY, Sarah et al.Journal of acquired immune deficiency syndromes (1999). 2010, Vol 53, Num 2, pp 209-214, issn 1525-4135, 6 p.Article

The chemokine CCL5 regulates the in vivo cell surface expression of its receptor, CCR5LIN, Yea-Lih; METTLING, Clément; PORTALES, Pierre et al.AIDS (London). 2008, Vol 22, Num 3, pp 430-432, issn 0269-9370, 3 p.Article

Reduced maximal inhibition in phenotypic susceptibility assays indicates that viral strains resistant to the CCR5 antagonist maraviroc utilize inhibitor-bound receptor for entryWESTBY, Mike; SMITH-BURCHNELL, Caroline; MORI, Julie et al.Journal of virology. 2007, Vol 81, Num 5, pp 2359-2371, issn 0022-538X, 13 p.Article

Effects of CC chemokine receptor 5 (CCR5) inhibitors on the dynamics of CCR5 and CC-chemokine-CCR5 interactionsNAKATA, Hirotomo; KRUHLAK, Michael; KAMATA, Wakako et al.Antiviral therapy (London). 2010, Vol 15, Num 3, pp 321-331, issn 1359-6535, 11 p.Article

Cloning and Analysis of Sooty Mangabey Alternative Coreceptors That Support Simian Immunodeficiency Virus SIVsmm Entry Independently of CCR5ELLIOTT, Sarah T. C; RIDDICK, Nadeene E; COLLMAN, Ronald G et al.Journal of virology. 2012, Vol 86, Num 2, pp 898-908, issn 0022-538X, 11 p.Article

Population-Based Sequencing of the V3-loop Can Predict the Virological Response to Maraviroc in Treatment-Naive Patients of the MERIT TrialMCGOVERN, Rachel A; THIELEN, Alexander; JAMES, Ian et al.Journal of acquired immune deficiency syndromes (1999). 2012, Vol 61, Num 3, pp 279-286, issn 1525-4135, 8 p.Article

Species selectivity of small-molecular antagonists for the CCR5 chemokine receptorSAITA, Yuji; KONDO, Mitsuhiro; SHIMIZU, Yasuaki et al.International immunopharmacology. 2007, Vol 7, Num 12, pp 1528-1534, issn 1567-5769, 7 p.Article

Reappraisal of the historical selective pressures for the CCR5-A32 mutationDUNCAN, S. R; SCOFF, S; DUNCAN, C. J et al.Journal of medical genetics. 2005, Vol 42, Num 3, pp 205-208, issn 0022-2593, 4 p.Article

Antiviral Activity of Single-Dose PRO 140, a CCR5 Monoclonal Antibody, in HIV-Infected AdultsJACOBSON, Jeffrey M; SAAG, Michael S; MURGA, Jose D et al.The Journal of infectious diseases. 2008, Vol 198, Num 9, pp 1345-1352, issn 0022-1899, 8 p.Article

Estimating the infectivity of CCR5-tropic simian immunodeficiency virus SIV_mac251 in the gutWILSON, David P; MATTAPALLIL, Joseph J; LAY, Matthew D. H et al.Journal of virology. 2007, Vol 81, Num 15, pp 8025-8029, issn 0022-538X, 5 p.Article

A pharmacokinetic-pharmacodynamic model to optimize the phase IIa development program of maravirocROSARIO, Maria C; POLAND, Bill; SULLIVAN, John et al.Journal of acquired immune deficiency syndromes (1999). 2006, Vol 42, Num 2, pp 183-191, issn 1525-4135, 9 p.Article

Age-dependent role for CCR5 in antiviral host defense against herpes simplex virus type 2ANK, Nina; PETERSEN, Klavs; MALMGAARD, Lene et al.Journal of virology. 2005, Vol 79, Num 15, pp 9831-9841, issn 0022-538X, 11 p.Article

Engineered CCR5 superagonist chemokine as adjuvant in anti-tumor DNA vaccinationDORGHAM, Karim; ABADIE, Valérie; IGA, Mutsunori et al.Vaccine. 2008, Vol 26, Num 26, pp 3252-3260, issn 0264-410X, 9 p.Article

CCR5 targeted SIV vaccination strategy preventing or inhibiting SIV infectionBOGERS, W. M. J. M; BERGMEIER, L. A; OOSTERMEIJER, H et al.Vaccine. 2004, Vol 22, Num 23-24, pp 2974-2984, issn 0264-410X, 11 p.Article

Efficiency of CCR5 Coreceptor Utilization by the HIV Quasispecies Increases over Time, But Is Not Associated with Disease ProgressionREDD, Andrew D; LAEYENDECKER, Oliver; QUINN, Thomas C et al.AIDS research and human retroviruses. 2012, Vol 28, Num 3, pp 289-294, issn 0889-2229, 6 p.Article

HIV Inhibition by CD4 and CCR5-Derived GlycopeptidesPERDOMO, Maria F; SÄLLBERG, Matti; VAHLNE, Anders et al.AIDS research and human retroviruses. 2012, Vol 28, Num 9, pp 852-858, issn 0889-2229, 7 p.Article

Analyses of Anti-HIV Type 1 Activity of a Small CCR5 Peptide AntagonistFANG YU WANG; SHU YA HE; ZHI JIAN ZHANG et al.AIDS research and human retroviruses. 2011, Vol 27, Num 10, pp 1111-1115, issn 0889-2229, 5 p.Article

A Novel Chemokine-Receptor-5 (CCR5) Blocker, SCH532706, Has Differential Effects on CCR5⁺CD4⁺ and CCR5⁺CD8⁺ T Cell Numbers in Chronic HIV InfectionPETT, Sarah L; ZAUNDERS, John; BAILEY, Michelle et al.AIDS research and human retroviruses. 2010, Vol 26, Num 6, pp 653-661, issn 0889-2229, 9 p.Article

Distribution of CCR5-A32, CCR2-641, SDF1-3'A, CX3CR1-249I, and CX3CR1-280M in Chinese PopulationsYUAN QIAN; HAO SUN; KEQIN LIN et al.AIDS research and human retroviruses. 2008, Vol 24, Num 11, pp 1391-1397, issn 0889-2229, 7 p.Article

New treatment options for HIV salvage patients : An overview of second generation Pls, NNRTIs, integrase inhibitors and CCR5 antagonistsHUGHES, Amelia; BARBER, Tristan; NELSON, Mark et al.The Journal of infection. 2008, Vol 57, Num 1, pp 1-10, issn 0163-4453, 10 p.Article